Liver Center of Texas

12/27/2021

12/27/2021

10/15/2020

Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study. at bit.ly/2I2GWkt

This study is the largest reported cohort of CLD and cirrhosis patients with SARS-CoV-2 infection to date. The authors demonstrate that baseline liver disease stage and ALD are independent risk factor for death from COVID-19. These data have important implications for the risk stratification of patients with CLD across the globe during the COVID-19 pandemic.

04/08/2020

We are available to assist your liver related disease and health needs during the COVID-19 lock down via Telehealth or Telemedicine. Stay safe

04/08/2020

Follow the simple guidelines as mandated by CDC (Centers for Disease Control), we all can save each other

04/02/2020

CoviD-19

If you have cirrhosis of the liver or on immunosuppressive (Prednisone, Azathioprine. Prograf, Cellcept etc). Please take care to make sure you follow the CDC guideline to protect yourself from COVID-19. You are at a higher risk of getting the infection.

Be Safe and best wishes to you and family.